Abstract
Radiofrequency ablation (RFA) is a relatively new treatment modality being applied to non-small cell lung cancer. Currently, it must be considered a third-line treatment in this clinical setting, after surgery and radiation therapy. Also, it has not received approval by the Food and Drug Administration specifically for use in the lung. RFA has promise, nonetheless, as a minimally invasive means of achieving local control of lung tumors in carefully selected patients. This chapter reviews patient selection, procedural technique, complications, imaging findings, and outcomes associated with this procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174(1):57–9.
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol. 1996;3(11):929–35.
Miao Y, Ni Y, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res. 2001;99(2):265–71.
Ahrar K, Price RE, Wallace MJ, et al. Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol. 2003;14(8):1037–43.
Nomori H, Imazu Y, Watanabe K, et al. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest. 2005;127(3):973–7.
Nguyen CL, Scott WJ, Young NA, Rader T, Giles LR, Goldberg M. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest. 2005;128(5):3507–11.
Ambrogi MC, Fontanini G, Cioni R, Faviana P, Fanucchi O, Mussi A. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg. 2006;131(5):1002–6.
Clasen S, Kettenbach J, Kosan B, et al. Delayed development of pneumothorax after pulmonary radiofrequency ablation. Cardiovasc Intervent Radiol. 2009;32(3):484–90.
Jaskolka JD, Kachura JR, Hwang DM, et al. Pathologic assessment of radiofrequency ablation of pulmonary metastases. J Vasc Interv Radiol. 2010;21(11):1689–96.
Hataji O, Yamakado K, Nakatsuka A, et al. Radiological and pathological correlation of lung malignant tumors treated with percutaneous radiofrequency ablation. Intern Med. 2005;44(8):865–9.
Vogl TJ, Naquib NN, Lehnert T, Nour-Eldin NE. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations—review article. Eur J Radiol. 2011;77(2):346–57.
Simon CJ, Dupey DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243(1):268–75.
De Pas TM, de Braud F, Catalano G, et al. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era. Ann Thorac Surg. 2007;83(1):231–4.
Khan AJ, Mehta PS, Zusag TW, et al. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006;81(2):163–7.
Grieco CA, Simon CJ, Mayo-Smith WW, Dipetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol. 2007;30(4):361–7.
Kishi K, Nakamura H, Sudo A, et al. Tumor debulking by radiofrequency ablation in hypertrophic pulmonary osteoarthropathy associated with pulmonary carcinoma. Lung Cancer. 2002;38(3):317–20.
Baisi A, Raveglia F, De Simone M, Cioffi U. Palliative role of percutaneous radiofrequency ablation for severe hemoptysis in an elderly patient with inoperable lung cancer. J Thorac Cardiovasc Surg. 2010;140(5):1196–7.
Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg. 2010;211(1):68–72.
McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121(4):1155–8.
Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132(1):193–9.
Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006;30(1):177–83.
Donohoo JH, Anderson MT, Mayo-Smith WW. Pacemaker reprogramming after radiofrequency ablation of a lung neoplasm. AJR Am J Roentgenol. 2007;189(4):890–2.
Iguchi T, Hiraki T, Gobara H, et al. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol. 2007;18(6):733–40.
Ambrogi MC, Fanucchi O, Lencioni R, Cioni R, Mussi A. Pulmonary radiofrequency ablation in a single lung patient. Thorax. 2006;61(9):828–9.
Sofocleous CT, May B, Petre EN, et al. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR Am J Roentgenol. 2011;196(5):W606–12.
Hess A, Palussière J, Goyers JF, Guth A, Aupèrin A, de Baère T. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258(2):635–42.
Hotta K, Matsuo K, Kiura K, Ueoka H, Tanimoto M. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer. Curr Opin Oncol. 2006;18(2):144–50.
Volpe ML, Piazza O, Palumbo D, et al. Conscious analgosedation for radiofrequency ablation of lung neoplasm. Minerva Anestesiol. 2006;72(3):111–5.
Hoffmann RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors—is there a difference between treatment under general anaesthesia and under conscious sedation? Eur J Radiol. 2006;59(2):168–74.
Pouliquen C, Kabbani Y, Saignac P, Gékière JP, Palussèire J. Radiofrequency ablation of lung tumours with the patient under thoracic epidural anaesthesia. Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S178–81.
Louie J, McGahan JP, Moore EH, Goodnight J, Brock J. Radio frequency ablation of lung metastasis using sonographic guidance. J Ultrasound Med. 2004;23(9):1241–4.
Lee EW, Suh RD, Zeidler MR, et al. Radiofrequency ablation of subpleural lung malignancy: reduced pain using an artificially created pneumothorax. Cardiovasc Intervent Radiol. 2009;32(4):833–6.
Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol. 2009;32(3):478–83.
Zhu JC, Yan TD, Glenn D, Morris DL. Radiofrequency ablation of lung tumors: feasibility and safety. Ann Thorac Surg. 2009;87(4):1023–8.
Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer. 2007;109(7):1397–405.
VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience—technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol. 2005;184(2):381–90.
Mori T, Kawanaka K, Ohba Y, et al. Diaphragm perforation after radio-frequency ablation for metastatic lung cancer. Ann Thorac Cardiovasc Surg. 2010;16(6):426–8.
Thornton RH, Solomon SB, Dupuy DE, Bains MS. Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. AJR Am J Roentgenol. 2008;191(2):565–8.
Hiraki T, Gobara H, Mimura H, et al. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol. 2010;21(7):1129–33.
Le TX, Andrews RT. Thermal osteonecrosis of the rib after radiofrequency ablation in the thorax. J Vasc Interv Radiol. 2008;19(6):940–4.
Ambrogi MC, Dini P, Melfi F, Mussi A. Radiofrequency ablation of inoperable non-small cell lung cancer. J Thorac Oncol. 2007;2(5 Suppl):S2–3.
Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer—a preliminary report of 33 patients. AJR Am J Roentgenol. 2004;183(4):1003–11.
Cariati M, Giordano G, Midulla M. Radiofrequency ablation of pulmonary lesions. Radiol Med. 2007;112(2):149–56.
de Baère T, Palussière J, Aupérin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587–96.
Gadaleta C, Catino A, Ranieri G, et al. Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother. 2004;16 Suppl 5:86–9.
Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol. 2007;62(7):639–44.
Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg. 2007;134(4):857–64.
Yoshimatsu R, Yamagami T, Terayama K, Matsumoto T, Miura H, Nishimura T. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest. 2009;135(4):1002–9.
Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol. 2006;17(10):1625–9.
Sakurai J, Hiraki T, Mukai T, et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol. 2007;18(1 Pt 1):141–5.
Cannella M, Cornelis F, Descat E, et al. Bronchopleural fistula after radiofrequency ablation of lung tumours. Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S171–4.
Nachiappan AC, Sharma A, Shepard JA, Lanuti M. Radiofrequency ablation in the lung complicated by positive airway pressure ventilation. Ann Thorac Surg. 2010;89(5):1665–7.
Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation—an international study survey. Anticancer Res. 2004;24(1):339–43.
Vaughn C, Mychaskiw 2nd G, Sewell P. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg. 2002;94(5):1149–51.
Fattorutto M. Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. Anesth Analg. 2003;96(4):1233; author reply 1234.
Nour-Eldin NE, Naguib NN, Mack M, Abskharon JE, Vogl TJ. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol. 2011;21(1):197–204.
Sakurai J, Mimura H, Gobara H, Hiraki T, Kanazawa S. Pulmonary artery pseudoaneurysm related to radiofrequency ablation of lung tumor. Cardiovasc Intervent Radiol. 2010;33(2):413–6.
Ghaye B, Bruyère PJ, Dondelinger RF. Nonfatal systemic air embolism during percutaneous radiofrequency ablation of a pulmonary metastasis. AJR Am J Roentgenol. 2006;187(3):W327–8.
Jeannin A, Saignac P, Palussière J, Gékière JP, Descat E, Lakdja F. Massive systemic air embolism during percutaneous radiofrequency ablation of a primary lung tumor. Anesth Analg. 2009;109(2):484–6.
Yamamoto A, Matsuoka T, Toyoshima M, et al. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging. AJR Am J Roentgenol. 2004;183(6):1785–9.
Rose SC, Fotoohi M, Levin DL, Harrell JH. Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol. 2002;13(10):1051–4.
Tanigawa N, Kariya S, Kojima H, et al. Cerebral microembolisation during radiofrequency ablation of lung tumours: detection by carotid duplex ultrasound. Br J Radiol. 2009;82(975):249–53.
Jin GY, Lee JM, Lee YC, Han YM. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor. AJR Am J Roentgenol. 2004;182(4):990–2.
Ahrar K, Stafford RJ, Tinkey PT, et al. Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices. J Vasc Interv Radiol. 2007;18(7):929–35.
Steinke K, King J, Glenn D, Morris DL. Percutaneous radiofrequency ablation of lung tumors: difficulty withdrawing the hooks resulting in a split needle. Cardiovasc Intervent Radiol. 2003;26(6):583–5.
Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230(1):125–34.
Radvany MG, Allan PF, Frey WC, Banks KP, Malave D. Pulmonary radiofrequency ablation complicated by subcutaneous emphysema and pneumomediastinum treated with fibrin sealant injection. AJR Am J Roentgenol. 2005;185(4):894–8.
Okuma T, Matsuoka T, Yamamoto A, et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol. 2008;31(1):122–30.
Lanuti M, Sharma A, Digumarthy SR, et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2009;137(1):160–6.
Hiraki T, Gobara H, Mimura H, et al. Aspergilloma in a cavity formed after percutaneous radiofrequency ablation for lung cancer. J Vasc Interv Radiol. 2009;20(11):1499–500.
Yamakado K, Akeboshi M, Nakatsuka A, et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol. 2005;28(4):530–2.
Hiraki T, Mimura H, Gobara H, et al. Two cases of needle-tract seeding after percutaneous radiofrequency ablation for lung cancer. J Vasc Interv Radiol. 2009;20(3):415–8.
Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation—preliminary results. Radiology. 2003;229(3):821–9.
Jin GY, Lee JM, Lee YC, Han YM, Lim YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol. 2004;183(4):1013–20.
Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185(2):466–71.
Sharma A, Digumarthy SR, Kalra MK, Lanuti M, Shepard JA. Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors. AJR Am J Roentgenol. 2010;194(5):1250–6.
Okuma T, Matsuoka T, Okamura T, et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med. 2006;47(8):1351–8.
Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med. 2006;20(2):115–21.
Akeboshi M et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15(5):463–70.
Singnurkar A, Solomon SB, Gönen M, Larson SM, Schöder H. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. J Nucl Med. 2010;51(12):1833–40.
Deandreis D, Leboulleux S, Dromain C, et al. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology. 2011;258(1):270–6.
Hiraki T, Mimura H, Gobara H, et al. Repeat radiofrequency ablation for local progression of lung tumors: does it have a role in local tumor control? J Vasc Interv Radiol. 2008;19(5):706–11.
Rubins J, Unger M, Colice GL, American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007;132(3 Suppl):355S–67S.
Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003;76(4):1001–7; discussion 1007–8.
Thanos L, Mylona S, Pomoni M, et al. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg. 2006;30(5):797–800.
Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg. 2005;129(3):639–44.
Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J. 2006;27(3):556–63.
Camacho Romero J, Oliver Goldaracena JM, RodrÃquez Caravaca G, Hernando Polo S, Martel Villagrán J, Trapero M. [CT-guided radiofrequency ablation of non-small cell lung cancer]. Med Clin (Barc). 2010;135(13):581–5.
Decker RH, Tanoue LT, Colasanto JM, Detterbeck FC, Wilson LD. Evaluation and definitive management of medically inoperable early-stage non-small-cell lung cancer. Part 1: assessment and conventional radiotherapy. Oncology. 2006;20(7):727–36.
Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25(8):947–52.
Steinke K, Glenn D, King J, Morris DL. Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions. Br J Radiol. 2003;76(910):742–5.
Okuma T, Matsuoka T, Yamamoto A, et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol. 2010;33(4):787–93.
Beland MD, Wasser EJ, Mayo-Smith WW, Dupuy DE. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. Radiology. 2010;254(1):301–7.
Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621–8.
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25 Suppl 1:S69–83.
Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue—is microwave not just for popcorn anymore? Radiology. 2009;251(3):617–8.
Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247(3):871–9.
Sharma A, Moore WH, Lanuti M, Shepard JA. How I do it: radiofrequency ablation and cryoablation of lung tumors. J Thorac Imaging. 2011;26(2):162–74.
Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129(3):738–45.
Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol. 2006;17(7):1117–24.
Mukai T, Mimura H, Gobara H. Radiofrequency ablation followed by radiation therapy for large primary lung tumors. Acta Med Okayama. 2007;61(3):177–80.
Banovac F, Cheng P, Campos-Nanex E, et al. Radiofrequency ablation of lung tumors in swine assisted by a navigation device with preprocedural volumetric planning. J Vasc Interv Radiol. 2010;21(1):122–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Scalzetti, E.M. (2013). Radiofrequency Ablation of Primary Lung Cancer. In: Ravenel, J. (eds) Lung Cancer Imaging. Contemporary Medical Imaging. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-620-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-620-7_10
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-60761-619-1
Online ISBN: 978-1-60761-620-7
eBook Packages: MedicineMedicine (R0)